EGFR and ovarian cancer: Although EGFR nuclear translocation can be expected to activate DNA-PK as a counter measure to DNA damage due to quercetin and PAC-9 treatment, immunofluorescence microscopy analysis revealed downregulation of DNA-PK in ovarian cancer cells exposed to quercetin aglycone or PAC DP-9.